Skip to main content

UBS Group AG

Position in STOK — Stoke Therapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in STOK

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$6,776,702
+$1,622,325 QoQ
Shares Held
207,112
+30.8% QoQ
Ownership
0.321%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#44
of 198 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in STOK Over Time

Shares Held

Position Value (USD)

Derivatives in STOK

reported options exposure · as of Mar 31, 2021
CallValue
$1,204,040
CallShares
31,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. STOK ranks #129 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in STOK

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,776,702 207,112
2026-03-31 $5,154,377 158,304
2025-12-31 $5,386,689 169,713
2025-09-30 $7,191,869 306,037
2025-06-30 $4,003,315 352,715
2025-03-31 $1,142,676 171,831
2024-12-31 $1,961,619 177,844
2024-09-30 $962,454 78,312
2024-06-30 $1,597,611 118,254
2024-03-31 $532,102 39,415
2023-12-31 $156,605 29,773
2023-09-30 $79,883 20,275
2023-06-30 $245,350 23,081
2023-03-31 $117,260 14,077
2022-12-31 $136,031 14,738
2022-09-30 $47,405 3,692
2022-03-31 $1,093,358 51,941
2021-12-31 $1,038,215 43,277
2021-09-30 $834,762 32,813
2021-06-30 $142,785 4,242
2021-03-31 $1,204,040 31,000
2021-03-31 $594,834 15,315
2020-12-31 $1,356,267 21,900
2020-03-31 $100,302 4,380